JAMES HEALY Transaction History

Date Transaction Value Shares Traded Form
Feb 05 2013
BUY
Conversion of derivative security
-
1,765,117
Jan 31 2013
BUY
Open market or private purchase
$3,000,000 $8.0 p/Share
375,000

Also insider at

CHRS
Coherus BioSciences, Inc. Healthcare
BOLT
Bolt Biotherapeutics, Inc. Healthcare
NTRA
Natera, Inc. Healthcare
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
KRTX
Karuna Therapeutics, Inc. Healthcare
CINC
CinCor Pharma, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
RAPP
Rapport Therapeutics, Inc.
BIOA
BioAge Labs, Inc.
JH

James Healy

Director
Menlo Park, CA

Track Institutional and Insider Activities on HGEN

Follow HUMANIGEN, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HGEN shares.

Notify only if

Insider Trading

Get notified when an Humanigen, Inc insider buys or sells HGEN shares.

Notify only if

News

Receive news related to HUMANIGEN, INC

Track Activities on HGEN